These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31778883)

  • 21. NGAL and cystatin C: two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: one year follow up.
    Papadopoulou-Marketou N; Skevaki C; Kosteria I; Peppa M; Chrousos GP; Papassotiriou I; Kanaka-Gantenbein C
    Hormones (Athens); 2015; 14(2):232-40. PubMed ID: 25402375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
    J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
    Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
    Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cystatin C as an early marker of diabetic nephropathy in patients with type 2 diabetes.
    Jeon YL; Kim MH; Lee WI; Kang SY
    Clin Lab; 2013; 59(11-12):1221-9. PubMed ID: 24409655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is serum cystatin C an accurate endogenous marker of glomerular filteration rate for detection of early renal impairment in patients with type 2 diabetes mellitus?
    El-Shafey EM; El-Nagar GF; Selim MF; El-Sorogy HA; Sabry AA
    Ren Fail; 2009; 31(5):355-9. PubMed ID: 19839834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing the GFR estimation equations using both creatinine and cystatin c to predict the long-term renal outcome in type 2 diabetic nephropathy patients.
    Pan Y; Jiang S; Qiu D; Shi J; Zhou M; An Y; Ge Y; Xie H; Liu Z
    J Diabetes Complications; 2016; 30(8):1478-1487. PubMed ID: 27593903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy.
    Aksun SA; Ozmen D; Ozmen B; Parildar Z; Mutaf I; Turgan N; Habif S; Kumanlioğluc K; Bayindir O
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):195-200. PubMed ID: 15127324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between serum cystatin C and diabetic peripheral neuropathy: a cross-sectional study of a Chinese type 2 diabetic population.
    Hu Y; Liu F; Shen J; Zeng H; Li L; Zhao J; Zhao J; Lu F; Jia W
    Eur J Endocrinol; 2014 Nov; 171(5):641-8. PubMed ID: 25184282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between Serum Irisin and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis.
    Wang R; Liu H
    Horm Metab Res; 2021 May; 53(5):293-300. PubMed ID: 33962476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relationship between Serum Cystatin C and Vascular Complications in Type 2 Diabetes Mellitus Patients with Normal Renal Function].
    Lu YA; Li W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Dec; 42(6):795-800. PubMed ID: 33423728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum cystatin C may predict the early prognostic stages of patients with type 2 diabetic nephropathy.
    Shimizu A; Horikoshi S; Rinnno H; Kobata M; Saito K; Tomino Y
    J Clin Lab Anal; 2003; 17(5):164-7. PubMed ID: 12938144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum Cystatin C as an Early Diagnostic Biomarker of Diabetic Kidney Disease in Type 2 Diabetic Patients.
    Qamar A; Hayat A; Ahmad TM; Khan A; Hasnat MNU; Tahir S
    J Coll Physicians Surg Pak; 2018 Apr; 28(4):288-291. PubMed ID: 29615169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum Cystatin C Trajectory Is a Marker Associated With Diabetic Kidney Disease.
    Wang N; Lu Z; Zhang W; Bai Y; Pei D; Li L
    Front Endocrinol (Lausanne); 2022; 13():824279. PubMed ID: 35634510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of Vitamin D-Binding Protein and Early Prediction of Nephropathy in Type 2 Saudi Diabetic Patients.
    Fawzy MS; Abu AlSel BT
    J Diabetes Res; 2018; 2018():8517929. PubMed ID: 29850609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of neutrophil gelatinase-associated lipocalin in diabetic nephropathy: a meta-analysis.
    Chen B; Li Y; Liu Y; Zang C; Wu M; Xu Z
    Ren Fail; 2019 Nov; 41(1):489-496. PubMed ID: 31215304
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
    Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G
    J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
    Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
    Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E-cadherin and periostin in early detection and progression of diabetic nephropathy: epithelial-to-mesenchymal transition.
    El-Dawla NMQ; Sallam AM; El-Hefnawy MH; El-Mesallamy HO
    Clin Exp Nephrol; 2019 Aug; 23(8):1050-1057. PubMed ID: 31104272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salivary and serum cystatin SA levels in patients with type 2 diabetes mellitus or diabetic nephropathy.
    Techatanawat S; Surarit R; Chairatvit K; Roytrakul S; Khovidhunkit W; Thanakun S; Izumi Y; Khovidhunkit SP
    Arch Oral Biol; 2019 Aug; 104():67-75. PubMed ID: 31174096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy.
    Wang S; Wang Y; Zheng R; Zhao Z; Ma Y
    Int J Clin Exp Pathol; 2015; 8(3):3110-5. PubMed ID: 26045825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.